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bstract
ackground  Identifying which patients with non-specific low back pain are likely to gain the greatest benefit from different treatments is an
mportant research priority. Few studies are large enough to produce data on sub-group effects from different treatments. Data from existing
arge studies may help identify potential moderators to use in future individual patient data meta-analyses.
bjective  To systematically review papers of therapist delivered interventions for low back pain to identify potential moderators to inform
n individual patient data meta-analysis.
ata  sources  We searched MEDLINE, EMBASE, Web of Science and Citation Index and Cochrane Register of Controlled
rials (CENTRALhttp://www.cochrane.org/editorial-and-publishing-policy-resource/cochrane-central-register-controlled-trials-central) for
elevant papers.
ata  extraction  and  data  synthesis  We screened for randomised controlled trials with ≥500 or more participants, and cohort studies
f ≥1000 or more participants. We examined all publications related to these studies for any reported moderator analyses. Two reviewers
ndependently did risk of bias assessment of main results and quality assessment of any moderator analyses.
esults  We included four randomised trials (n  = 7208). Potential moderators with strong evidence (p  < 0.05) in one or more studies were
ge, employment status and type, back pain status, narcotic medication use, treatment expectations and education. Potential moderators with
eaker evidence (0.05 < p  ≤  0.20) included gender, psychological distress, pain/disability and quality of life.
onclusion  There are insufficient robust data on moderators to be useful in clinical practice. This review has identified some important
otential moderators of treatment effect worthy of testing in future confirmatory analyses.
 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
icenses/by-nc-nd/4.0/).
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ackground
Low back pain (LBP) is very common and has a large
ersonal and societal cost [1]. Most LBP is classified as
on-specific LBP (NSLBP) which affects one-third of the
opulation each year [2]. There is good evidence to show
hat several treatment approaches are effective, and that some
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.R.Ellard@warwick.ac.uk (D.R. Ellard), D.Mistry@warwick.ac.uk
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f these are cost-effective [2]. The effect sizes are of simi-
ar magnitude for different approaches [3–6]. However, the
ean effect size from these treatments is, at best, small to
oderate and may be short lived. Typically, the mean effect
izes, on current outcome measures, are substantially smaller
han the minimally detectable change for an individual. Thus,
ost of the patients who receive a particular treatment will
ot gain a noticeable additional benefit from treatment [7]. At
 population level, we have useful data on the management
f LBP. What is not clear is how we can use these data to
aximise the treatment benefit for the individual patient, or
o identify those who will respond to different treatment and
arget treatment accordingly. Identifying which patients are
icle under the CC BY-NC-ND license (http://creativecommons.org/licenses/
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ikely to gain the greatest benefit from different treatments
or LBP is an identified research priority [8] and was one of
he key recommendations for future research in UK National
nstitute for Health and Clinical Excellence (NICE) back pain
uidelines [9].
In clinical practice, to try to maximise treatment bene-
t, subgrouping is used for patients with LBP despite lack
f evidence that results vary between subgroups [10]. NICE
onsiders identification of subgroups as an important part in
heir decision making on whether the technology is clinically
ffective or cost-effective [4]. In order to develop such sub-
roups a clear understanding of the potential moderators of
reatment is required.
Many studies have examined predictors of outcome from
BP [11–13]. These do not, however, identify moderators;
hose factors indicating who is likely to gain largest bene-
t from a particular treatment. Mediators, measured during
reatment, identify potential mechanisms that have an inter-
ctive effect on outcome [14]. This review solely focuses
n moderators of treatment response; factors measured prior
o randomisation that affect whether an individual has a
reater, or lesser benefit from treatment [15]. Identification of
otential effect modifiers needs sufficient statistical power to
etect an interaction between the moderators and treatment
16].
Any RCT designed to test effects in subgroups will need
o be several times larger than nearly all existing RCTs. Most
rials simply compare the effects of two interventions with
ne primary outcome measure. More complex designs test-
ng multiple baseline measures, and multiple interventions,
ould be implausibly large. However, many participants are
ow included in RCTs, in some cases testing similar inter-
entions and most using very similar outcome measures.
ombining data from these trials could provide a more cost-
ffective way of exploring and testing for moderator effects
ithout the expense of a large costly and time consuming
rial.
ims  &  objectives
The aim of this systematic review was to inform hypothe-
is development for an individual patient data meta-analysis
or moderators of therapist delivered interventions in RCTs.
herefore the question being addressed was are there sub-
roups of patients with low back pain, receiving therapist
elivered interventions that do better or worse?
To achieve this our objectives were:
 To search the relevant literature in the field.
 To screen the literature based on predefined inclusion crite-
ria.
 To extract data and quality assess the literature.
 To highlight the potential moderators from the literature to
apply to an individual patient data meta-analysis.
o
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wy 101 (2015) 243–251
ethods
ligibility  criteria
The following inclusion criteria was pre specified:
(a) RCTs with sample size of ≥500, non-RCTs and obser-
vational studies with sample size ≥1000 published in
English language; see below for justification of the 500
cut-off.
b) Participants aged 18 years or more with history of
NSLBP of any duration.
(c) Therapist delivered interventions for LBP examining the
effect of patient preference and expectations, and indi-
vidual predictors.
d) Primary and secondary analysis papers of RCTs seeking
to identify predictors of response to treatment using a
‘priori’ and ‘post hoc’ subgroups and those looking for
interaction between baseline variable and treatment.
We only included studies of people with NSLBP. We
xcluded studies with no comparison between two treatment
roups and studies that did not report effect sizes for treatment
y using moderator interactions.
nformation  sources
We searched MEDLINE (1948 to September 2011), Ovid
EDLINE(R) In-Process & Other Non-Indexed Citations,
MBASE (1974 to September 2011), Web of Science and
itation Index and Cochrane Controlled Trial Registered
CENTRAL) databases for relevant papers. The searches
ere updated in May 2013 then again in July 2014.
earch  criteria
Preliminary searches were carried out by using search
erms such as ‘low back pain’ combined with keywords
ike ‘subgroup’, ‘effect modifier’ and ‘moderator’. How-
ver this only yielded publications that had terms ‘subgroup’
n the title/abstract only, missing out publications that had
he term ‘subgroup’ in the main text. We therefore re-ran
earches using keywords (‘trial’) for RCTs and (‘Observa-
ional’, ‘Cohort’, ‘Prospective studies’) for non-RCTs or
bservational studies separately and then combining them
ith terms ‘low back pain’ (see Supplementary file 1). Hand
earching and screening of included studies were carried out
or additional studies.
tudy  selection  and  data  extraction
Two authors (TG & DE) scanned titles and abstracts based
n the pre-specified inclusion criteria. Data extraction was
arried out by two reviewers (TG & DE) independently, using
 standardised data extraction form. A third reviewer (MU)
as available to consult if there were discrepancies.
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A pre-piloted form was used to extract relevant data inde-
endently on study (e.g., author, country, design, sample
ize), participants (e.g., age, sex, level and year of education,
mployment status, back pain history and current episode of
ack pain), interventions (e.g., manipulation, exercise, cog-
itive behavioural therapy and acupuncture), and outcome
haracteristics (e.g., scale of measurement such as RMDQ
nd modified von Korff (MVK) scales of pain and disability).
he extracted data were cross-checked by second reviewer
nd any disagreement were sorted by discussion.
One of the criteria for including clinical trials in this review
s that the sample size was adequate for meaningful subgroup
nd/or interaction effect analyses. For the sample size crite-
ion, we assumed that the outcome of interest is continuous
nd normally distributed, there are two treatment arms (inter-
ention and control) and the potential moderator is binary.
e used a simple model proposed by Lachenbruch [19] to
etermine the minimum sample size needed to test for an
nteraction effect. To test for a long-term (12 months) moder-
te standardised effect size of 0.5 for the interaction at a 0.05
evel of significance and 80% power, a minimum data-set
f 503 participants was needed. An additional file shows the
ample size calculation in more detail [see Supplementary file
]. Therefore any variables identified as moderators of treat-
ent effect at p < 0.05 were credible for the purpose of our
eview. However, there might be a number of other variables
hose effect approaches statistical significance and might be
otential moderators that were not detected as the sample size
f the trial is insufficient to make it a statistically significant
nding.
To put this into context the effect sizes of the high-quality
CTs of therapist delivered interventions for low back pain
re typically in range 0.12 to 0.23 [6]. Thus, any trial smaller
han our size criterion would only be able to detect treatment
oderation if the moderation effect was substantially larger
han the main treatment effect.
ata  items
For this study we did not pre-define the moderator vari-
bles of interest. We were, rather, seeking to identify the
otential moderators identified by others to allow us to define
-priori the variables of interest in our subsequent IPD meta-
nalysis. Artificially restricting variables of interest at this
tage of the process might have run the risk of introducing
ias into the selection process.
isk  of  bias
This was carried out by two reviewers (XX, XX) using
he ‘Cochrane Collaboration risk of bias tool’. The criteria
sed were: (a) method of randomisation, (b) allocation con-
ealment, (c) incomplete outcome data, (d) selective outcome
eporting, and (e) other source of bias [17]. Where a study had
t
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ultiple publications, risk of bias assessment was conducted
n the paper containing the main study findings.
ummary  measures
The purpose of this review was to identify variables to
e included in a subsequent individual patient data meta-
nalysis. For this reason we report all interactions with a
-value of ≤0.20 to ensure all possible moderators were iden-
ified and present the mean difference with 95% confidence
nterval for the interaction between treatment and baseline
ariable for each subgroup. Therefore we considered modera-
ors as those with strong (p  < 0.05) or weak evidence (p  < 0.20,
0.05).
The primary outcome of clinical interest here is the size
f the interaction between baseline variables and treatment.
his is a measure of the differential sub-group effect. That
s the size of the difference in the average effect of treat-
ent between two groups defined by a baseline characteristic
moderator). Where provided in the original papers we report
his as a point estimate with a 95% confidence interval. Where
nly a ‘p’ value is reported it is that which have presented.
or our current purpose we are not actually trying to estimate
he magnitude of any clinical effect we are simply seeking
o identify potential moderators based on the level of signif-
cance of any interactions identified. It is thus the ‘p’ value
hat becomes our primary summary measure of outcome for
his study.
ynthesis  of results
Although the same moderators were investigated in sev-
ral studies, it was not possible to perform meta-analyses due
o statistical heterogeneity.
uality  of  moderator  analysis
The quality assessment of subgroup analyses within stud-
es was carried out using the Pincus criteria [18] which
lassifies the level of evidence into confirmatory evidence or
xploratory evidence. Members of the reviewing team who
ere authors on any included studies did not participate in
he quality assessment exercises.
esults
We identified 7208 citations in total including all the
pdated searches. 6294 were removed based on title, abstract
nd duplicates. The full texts of 64 papers were retrieved for
urther evaluation; 60 of these did not meet our inclusion
riteria (Fig. S1).We included analyses from four RCTs [3,5,20,24] and
heir published secondary papers [7,20–24] (n  = 5514),
enceforth named the ‘UK BEAM’, ‘BeST’, ‘Witt’ and
Cherkin’ trial (Table 1). Our sample size calculation for our
246 T. Gurung et al. / Physiotherapy 101 (2015) 243–251
Table 1
Characteristics of included studies.
Study ID Inclusion criteria/sample size (N) Intervention Follow up Outcomes
BeST Trial
United Kingdom
(Lamb et al., HTA,
2010, 14; Underwood
et al., Arthritis Care
Res, 2011;63:1271)
Inclusion criteria: Participants had attended general
practice with sub-acute and chronic LBP, who were
experiencing symptoms of at least moderate
troublesomeness for >6 weeks. Low back pain presents
in a wide variety of ways, and typically patients present
with a spectrum of severity and chronicity, participants
had to be aged 18 years or older, participants were able
to give informed consent
N = 701
Active management
(advice only)
Advice plus
cognitive-behavioural
therapy
12 Months Roland Morris
Disability
Questionnaire
(RMDQ)
Modified von Korff
(MVK) scales of pain
and disability
Cherkin 2009
USA (Cherkin et al.,
Arch Intern Med,
2009;169:858;
Underwood et al.,
Arthritis Care Res,
2011;63:1271)
Inclusion criteria: LBP as presenting symptom on the
day of recruitment, written consent to participate in the
study, and age above 19 years
N = 638
Individualised
treatment
Standardised
acupuncture
Simulated
acupuncture
Usual care
8 Weeks
52 Weeks
Symptoms
Bothersomeness score
Back related
dysfunction (Roland
score)
UK BEAM Trial
Kingdom (UK
BEAM, BMJ,
2004;329:1377;
Underwood et al.,
Rheumatology,
2007;46:1297)
Inclusion criteria: 18 and 65 years of age; consulted
with simple low back pain -pain of musculoskeletal
origin in the area bounded by the lowest palpable ribs,
the gluteal folds, and the posterior axillary lines,
including pain referred into the legs provided it was
mainly above the knee; they had score of four or more
on the Roland disability questionnaire at randomisation;
agreed to avoid physical treatments, other than trial
treatments, for three months; experienced pain every
day for the 28 days before randomisation or for 21 out
of the 28 days before randomisation; and 21 out of the
28 days before that
N = 1334
Manipulation,
exercise,
Manipulation
followed by exercise
(combined treatment)
3 Months
12 Months
Scores on the Roland
Morris disability
questionnaires
Witt 2006
Germany (Witt et al.,
Clin J Pain,
2011;27:550)
Inclusion criteria: Clinical diagnosis of chronic low back
pain with disease duration of more than 6 months; age
≥18 years; and provision of written informed consent
N = 2841 (Randomised)
Immediate
acupuncture treatment
Delayed acupuncture
after 3 months
6 Months Back function or pain
improvement scores
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cnclusion criteria of an overall sample size of ≥500 was based
n a two arm trial i.e. 250 participants per arm. The Cherkin
rial met the inclusion criteria for an overall sample size of
500, however this was a four arm trial meaning the num-
er of participants in each arm was around 150. As this trial
till generated useable information, we decided to include it
nd revisit our search results to identify any trials that had an
verall sample size of ≥300. We did not identify any further
rial meeting this revised criterion.
For the Witt trial the moderator analyses were included
n the main paper [24]. For UK BEAM, BeST & Cherkin
he moderator analyses were presented in a secondary paper
7,22,23]. UK BEAM and BeST were carried out in the
K, Witt in Germany and Cherkin in the USA. Sample
izes ranged from 600 to 2841. Mean age ranged from 47
o 53 years and the majority of the participants were female
56% to 62%). The interventions in the included studies are
cupuncture [22,24], group cognitive behavioural approach
BeST) [21], group exercise (UK BEAM) [7], manual ther-
py (UK BEAM) and manual therapy followed by exercise
UK BEAM).
t
p
w
[Outcomes reported in the studies were Roland Morris Dis-
bility Questionnaire (RMDQ), back-related dysfunction and
othersomeness score, MVK (Modified Von Korff) pain and
isability, back function and pain improvement. Total follow-
p duration and the unit of measure used (e.g. months or
eeks) varied across the trials; ranging between three months
12 weeks) and 52 weeks. The characteristics of included
tudies are shown in Table 1. We did not identify any relevant
bservational studies.
isk  of  bias  and  results  of  RCTs
Risk of bias assessment was based on the main RCT results
aper of the included trials (Table 2). The method of randomi-
ation was explicit (low risk) in all four RCTs. Allocation
oncealment was adequate (low risk) in all trials. None of the
rials were described as double blinded (participant or thera-
ist) and rated as high risk; however in one study participants
ere blinded to treatment as sham treatment used in one arm
20] and in another study researchers doing assessments were
T. Gurung et al. / Physiotherapy 101 (2015) 243–251 247
Table 2
Cochrane collaboration risk of bias assessment (Higgins and Green, Cochrane handbook for systematic reviews of interventions, 2011).
Study ID Risk of Bias Assessment (RoBA)*
1 2 3 4 5 6 7 8 Funder
BeST Trial, United Kingdom (Lamb et al.,
HTA, 2010;14; Underwood et al., Arthritis
Care Res, 2011;63:1271)
L L H L L L L L NIHR HTA Programme
Cherkin Trial, USA (Cherkin et al., Arch
Intern Med, 2009;169:858; Sherman et al.,
BMC Musculoskelet Disord, 2009;10:114)
L L H L L L L L NIH Cooperative
agreement with National
Centre for
Complementary and
Alternative Medicine
UK BEAM Trial, United Kingdom (UK
BEAM, BMJ, 2004;329:1377; Underwood
et al., Rheumatology, 2007;46:1297)
L L H L L L L L Research Costs: Medical
Research Council
Treatment Costs: NHS,
Research and
Development (R&D)
Witt Trial, Germany (Witt et al., Clin J Pain,
2011;27:550)
L L H U U L U H A group of social health
fund providers
* RoBA, (1) random sequence generation, (2) allocation concealment, (3) blindin
reporting, (6) similarity of groups at baseline, (7) sample size calculation, (8) intent
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tively greater improvement in females compared to males inig. 1. Cochrane collaboration risk of bias assessment tool.
asked [21]. Three trials had no evidence of selective out-
ome reporting and dropout rate analyses were adequately
revented and were judged as being low risk [3,25,26]. The
ame three trials included an intention to treat (ITT) analysis
nd had adequate sample size based on power calculations
or the main comparison. Only one trial did not carry out an
TT analysis and provided unclear evidence of selective out-
ome reporting [24] (Fig. 1). BEST trial was funded by NIHR
TA programme, Cherkin trial by NIH cooperative agree-
ent with National centre for complementary and Alternative
edicine, UK BEAM Trial by Medical research council and
HS, Research and development and Witt trail by a group of
ocial health fund providers.
ethodological  quality  for  subgroups
The methodological quality of the moderator analyses var-
ed; BeST provided confirmatory evidence for fulfilling all
ve criteria for subgroup studies for two potential moderators
23]. Cherkin and UK BEAM provided exploratory evidence
t
e
Cg of participants and personnel, (4) incomplete outcome data, (5) selective
ion to treat analysis. L—low risk of bias, H—high risk of bias, U—unclear.
.e. they only met criteria three, four and five for subgroup
tudies [7,22] and Witt provided insufficient data to judge
uality of subgroup analyses [24] (Table 3).
oderator  variables  identiﬁed
Potential moderators with strong evidence (p  < 0.05) in
ne or more studies include age (younger participants may
ain more benefit), employment status and type (those
mployed or in sedentary occupations may gain greater
enefit), back pain status (those who are worse may gain
reater benefit), narcotic medication use (users may benefit
ess), treatment expectations (those with a greater positive
xpectation gained more benefit) and education (those with
reater than 10 years of schooling gained a greater benefit).
otential moderators with weaker evidence (0.05 < p  ≤  0.20)
nclude gender (female participants may gain greater bene-
t), psychological distress (those with anxiety and depressive
ymptoms may benefit more), pain/disability (those with
reater pain/disability at baseline may benefit more) and qual-
ty of life (those with a better quality of life may benefit more)
Table S1).
Interaction with age was found in the BeST, Cherkin and
itt trials [5,20,24]. Specifically a cognitive behavioural
pproach was more beneficial in younger participants than
lder participants on the RMDQ score. The evidence for this
as strong, with a treatment difference of −1.58 (p  = 0.035;
5% CI −3.05 to −0.12). Witt [24] also found a statistically
ignificant additional benefit from acupuncture treatment in
ounger participant (p  < 0.001).
A cognitive behavioural approach produced a compara-he BeST trial [5]. For the RMDQ score the treatment differ-
nce between male and female was −1.27 (p  = 0.102; 95%
I −2.79 to 0.25), providing some weak evidence.
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Table 3
Quality assessment of the treatment moderators (Pincus et al., BMC Med Res Methodol, 2011;11:14).
Study ID Was the
subgroup
analysis
specified
a-priori
Was the
selection of
subgroup
factors for
analysis the-
ory/evidence
driven
Were
subgroup
factors
measured
prior to
randomisation
Was measurement of
subgroup factors
measured by adequate
(reliable and valid)
measurements,
appropriate for the
target population
Does the analysis
contain an explicit
test of the
interaction
between
moderator and
treatment
Strength of
evidence
BeST (Lamb et al., HTA,
2010;14; Underwood et al.,
Arthritis Care Res,
2011;63:1271)
Yes Yes Yes Yes Yes Confirmatory
evidence (for
two variables
only)
Cherkin (Cherkin et al., Arch
Intern Med, 2009;169:858;
Sherman et al., BMC
Musculoskelet Disord,
2009;10:114)
No No Yes Yes Yes Exploratory
evidence
UK BEAM (UK BEAM,
BMJ, 2004;329:1377;
Underwood et al.,
Rheumatology,
2007;46:1297)
No No Yes Yes Yes Exploratory
evidence
Witt (Witt et al., Clin J Pain,
2011;27:550)
No No Unclear No Unclear Insufficient
evidence
Conﬁrmatory evidence: The study fulfilling all five criteria for moderator studies; Exploratory evidence: The study meeting only three, four and five criteria
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easurement of subgroup factors.
Being employed and the type of employment had
ome moderating effect. In the BeST trial [5] a cogni-
ive behavioural approach produced additional benefit in
mployed participants when compared to those who were
ot employed. Greater education also had a beneficial effect
n treatment outcome. In Witt [24], participants who have
ad more than 10 years of schooling gained a greater bene-
t from acupuncture (p  = 0.01). BeST [5] found a treatment
ifference of 1.29 (p  = 0.098; 95% CI −0.24 to 2.82) on the
MDQ score for participants leaving education after the age
f 16, this provides some weak evidence.
Manipulation treatment provided greater benefit at three
onths (p  = 0.176) and 12 months (p  = 0.143) for the RMDQ
core amount those with greater pain/disability at baseline
3]. The evidence for this is weak. Worse initial back pain
tatus also produced greater gain from acupuncture in the
herkin and Witt trials [20,24] when compared to those with
 better back pain status at baseline (p-values ranged from
0.001 to 0.16). There was a weak interactions for how trou-
lesome or bothersome back pain was perceived as, where
reater benefit from treatment was in those with a more trou-
lesome/bothersome condition.
Having better expectations about the treatment was found
o be a moderating factor with p-values ranging between
 = 0.03 and p  = 0.192 demonstrating a spectrum of strong
o weak evidence for the interactions.
Baseline anxiety and depression had a weak moderating
ffect. Greater baseline anxiety resulted in more benefit from
reatment in terms of the RMDQ score, the treatment differ-
nce was −1.12 (p  = 0.195; 95% CI −2.83 to 0.58). Those
c
i
p
vlicit test of interaction between moderator and treatment and inadequate
ith higher levels of depression gained more benefit from the
reatment than those who were less depressed for outcome of
MDQ and MVK disability score. The treatment difference
as found to be −2.07 (p  = 0.135; 95% CI −4.79 to 0.65) and
14.58 (p  = 0.051; 95% CI −29.19 to 0.03) for the RMDQ
nd MVK disability score, respectively.
iscussion
The aim of this review was to identify variables from
urrent evidence that are potential moderators of treatment
ffect; variables that have shown to have a possible benefi-
ial moderating effect (at a ≤0.20 level of significance) on
reatments for LBP. We were only able to include data from
our trials; two of these had considered subgroup analysis at
he design stage and only one of these (Witt) was powered to
how such an effect. Despite this, the Witt trial ranked poorly
n the quality assessment tools therefore caution should be
aken when interpreting or applying the findings. Across these
our trials a large number of moderator analyses were per-
ormed; not all of which were presented in the published
apers. We have only presented a small number of interac-
ions, some statistically significant and others approaching
tatistical significance. The likelihood of a statistically sig-
ificant finding increases when a large number of tests are
arried out. Thus caution is needed in interpreting the clin-
cal importance of any moderation that we have identified;
articularly as none of the trials were testing similar inter-
entions.
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As moderator variables have not been looked for in this
ay before it is hard to compare our findings to that of others.
ur findings do seem to concur with the findings of some of
he earlier work in this area particularly in the moderating
ffects of age and employment, moderate disability and fear
voidance belief on treatment [27,28]. We identified one fur-
her trial which, prima facia, reported that intervention effects
iffered with gender; but the analysis did not include a formal
est for interactions so we excluded it [29]. Our findings about
reatment expectations also concur with earlier work [30–32].
 systematic review of factors that influenced outcome from
elf-management programmes for chronic musculoskeletal
ain found that self-efficacy, depression, pain catastrophising
nd physical activity were important [33].
In an individual patient data meta-analysis of approxi-
ately 9990 participants with LBP, headache, neck pain or
steoarthritis it was found that gender, the living situation
f the patients, earlier positive acupuncture treatments and
 failure of other therapies were potential effect moderators
24]. We identified one additional publication using the UK
EAM data that suggested that a moderator analysis had been
one [34]. It did not, however, report interaction between
reatment group and work status or educational group or
ownsend score separately, rather it had combined them in
 single analysis; therefore we excluded it. The STarT Back
rial compared the overall effectiveness of an approach using
rognostic stratification and matched interventions for low,
edium and high risk subgroups, with usual best care for
ack pain after our searches had been completed. However,
nteractions for individual variables were not reported and it
ould therefore not have been eligible for inclusion in our
eview [35].
trengths  and  limitations
The main strength of this study is that, to our knowledge,
his is the first review to have looked at all papers related
o large trials that may plausibly show an interaction rather
han searching for subgroup effects. We only included sec-
ndary analysis data RCTs that were large enough to detect
 moderate standardised effect size for moderation of 0.5.
his ensured the credibility of the moderators identified from
hese studies for the purposes of our review. We carried out
 comprehensive systematic search separately for RCTs and
bservational studies to maximise identification of all pub-
ished studies related to low back pain. However we did not
nd any observational studies for inclusion. We used strict
nclusion and exclusion criteria to ensure high quality of
he included studies. None of the observational studies met
ur inclusion criteria. We used two quality assessment tools
 ‘Cochrane risk of bias assessment tool’ and ‘methodologi-
al tool for treatment moderators’, [18] to assess quality and
evel of evidence of the included studies.
We could not test for publication bias because we have
ncluded only four studies in our review. This meant that
he power of the test was too low to distinguish chance
F
ty 101 (2015) 243–251 249
rom real asymmetry [17] and statistical heterogeneity [36].
e presented secondary analysis and results of subgroup-
pecific analysis as reported in the published papers; hence
he findings should be interpreted with caution, as there
s a possibility of bias associated to many factors such as
nappropriate statistical methods and insufficient a priori
pecification of variables [37].
We included RCTs in which participants or therapist can-
ot be blinded/masked to treatment arm because of the nature
f the studies. However, these were all well-conducted RCTs
ith adequate concealment of allocation and adequate gen-
ration of the allocation sequence. In Witt et al., the only evi-
ence of a moderator effect came from a statement reported in
he paper [24]. We contacted the authors to clarify this point
ut they did not provide the actual data only the p-values.
The findings from our review provide some very weak
mpirical evidence that certain groups of patients might
erive a greater benefit from therapist delivered interventions.
he evidence is not strong enough to make clinical recom-
endations. The STarT Back trial found a stratified man-
gement approach with prognostic screening and targeted
reatments to be clinically and cost-effective [35] reinforcing
he need to develop an understanding of the characteristics
f patients who benefit the most from a given treatment.
There are still arguments, for and against, subgrouping
10]. It is unlikely that any single trial will be sufficiently
esourced to be statistically powered to do subgroup analyses
f all possible moderating variables; and no guarantee that
rials included in any individual patient data meta-analysis
ill be sufficiently homogenous to allow sub-group iden-
ification. It may be that seeking to identify subgroups in
linical trial data will fail to produce a useful clinical clas-
ification. In which case the back pain research community
hould consider developing clinically defined subgroups in
hich different interventions can be tested. Our challenge
ow is to explore the variables we have identified in individ-
al patient data (IPD) meta-analyses. However, we recognise
s part of this challenge that we have, almost certainly, not
dentified all of the potential moderators.
onclusion
This study provides some insight into the potential mod-
rators with strong (p  < 0.05) and weak (0.05 < p  ≤  0.20)
vidence. There are however insufficient robust data on
oderators to be useful in clinical practice. This review
as identified some important potential moderators of treat-
ent effect worthy of testing in future confirmatory analyses
lthough some caution is needed in interpreting the findings.unding
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